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Background: Reprocessing of endoscopes is key to preventing cross-infection after colonoscopy. Culture-
based methods are recommended for monitoring, but alternative and rapid approaches are needed to
improve surveillance and reduce turnover times. A molecular strategy based on detection of residual traces
from gut microbiota was developed and tested using a multicenter survey.
Methods: A simplified sampling and DNA extraction protocol using nylon-tipped flocked swabs was op-
timized. A multiplex real-time polymerase chain reaction (PCR) test was developed that targeted 6 bacteria
genes that were amplified in 3 mixes. The method was validated by interlaboratory tests involving 5 ref-
erence laboratories. Colonoscopy devices (n = 111) were sampled in 10 Italian hospitals. Culture-based
microbiology and metagenomic tests were performed to verify PCR data.
Results: The sampling method was easily applied in all 10 endoscopy units and the optimized DNA ex-
traction and amplification protocol was successfully performed by all of the involved laboratories. This
PCR-based method allowed identification of both contaminated (n = 59) and fully reprocessed endo-
scopes (n = 52) with high sensibility (98%) and specificity (98%), within 3-4 hours, in contrast to the 24-
72 hours needed for a classic microbiology test. Results were confirmed by next-generation sequencing
and classic microbiology.
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Conclusions: A novel approach for monitoring reprocessing of colonoscopy devices was developed and
successfully applied in a multicenter survey. The general principle of tracing biological fluids through mi-
croflora DNA amplification was successfully applied and may represent a promising approach for hospital
hygiene.
© 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier
Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Endoscopy plays an essential role in diagnosis and therapy of
several diseases.1 This costly and sophisticated approach is based
on reusable tools that need appropriate reprocessing to avoid
cross-infections.2 Because of the type of endoscopy, the cleaning
treatments used, and patient clinical features, the disinfection or
sterilization levels may vary in their efficacy requirements.3,4 Fail-
ures during reprocessing steps may occur, and contaminated
endoscopes have been associated with outbreaks of health care-
associated infections more frequently than any other medical
devices.2,5 Remarkably, endoscope-transmitted infections can occur
even when reprocessing is performed following professional and
manufacturer guidelines.5-7 Flexible endoscopes are significantly con-
taminated by biological fluids, including blood or secretions.6-8
Radical cleaning is a critical step due to the complex structure of
the devices, which are characterized by narrow lumens and mul-
tiple internal channels. Endoscope reprocessing is a challenging task
involving cleaning and high-level disinfection (HLD) treatments, fol-
lowed by rinsing and drying before appropriate storage.8-10
Reprocessing failures, as well as the ability of bacteria to form biofilm
on the inner channels and surface roughness, increase the likeli-
hood of health care-acquired infections.2,11-13 Education-based actions
and technical advancements can certainly improve reprocessing ef-
fectiveness and ensure proper safety levels throughmultidisciplinary
teamwork.2,12,14,15 Microbiologic surveillance by culture-based
methods represents an established and easy-to-use approach to
assess the effectiveness of reprocessing procedures, but relevant limi-
tations should be considered, such as long response time, low
specificity, and poor sensitivity, in detecting resistant microorgan-
isms not cultivable on standard media such as viruses, protozoa,
prions, or viable but not cultivable bacteria.6,13,15-17
Recently, rapid biochemical methods, based on the evaluation
of ATP, protein, carbohydrate, or hemoglobin levels, have been pro-
posed to assess removal of organic residues from endoscopes.7,18,19
However, several shortcomings, such as aspecific output, low sen-
sitivity, and interference with disinfectants, suggests further
improvements are needed.18,19 DNA-based techniques, including real-
time polyerase chain reaction (PCR), may indeed show several
advantages in comparison with traditional culture-based methods
in that they are less time-consuming, highly specific and sensi-
tive, affordable, and can detect viable but not cultivable bacteria.20,21
The potential application of molecular techniques represents a very
promising and challenging opportunity to further improve moni-
toring of reprocessed devices. Here, we report the use of a novel
method to monitor the effectiveness of reprocessing by an opti-
mized real-time PCR approach that was evaluated on colonoscopy
devices using a multicenter survey. The general principle of the
method was based on the observation that residual traces of bio-
logical fluid microflora (mf) on reprocessed devices represent a
potential indicator of sanitation failure, when tested by an mfDNA-
based approach.22 The identification and characterization of biological
fluid by mfDNA analysis were initially applied in forensics and then
hospital hygiene in dental settings.22,23 In this study, sampling and
DNA extraction were developed and validated within interlaboratory
tests to achieve a simple and rapid protocol for a routine monitor-
ing. Next-generation sequencing (NGS) analysis on selected mfDNA
samples was carried out to confirm the molecular data. The general
principle of tracing biological fluids through mfDNA amplification
was applied in a multicenter study, suggesting promising perspec-
tives for surveillance.
MATERIALS AND METHODS
Setting and study design
This studywas conducted in themain hospitals of different Italian
regions (Campania, Emilia Romagna, Lazio, Liguria, Marche, Molise,
Tuscany, Veneto, Sardinia, and Sicily) involving 10 endoscopy units
that reprocess approximately 50-100 endoscopes per business day.
Data were collected by the Coordinating Laboratory Unit in Rome
(Lazio, Foro Italico). Following a checklist, each participant unit (PU)
provided information on endoscopy devices and reprocessing pro-
cedures or locally available guidelines, department and referent
identification, and documentation on the reusable instruments sub-
jected to sanitization. Each PU received a kit containing nylon-
tipped flocked swabs with drying active agent (4N6FLOQSwabs;
Genetics, Copan Italia, Brescia, Italy) and information on sampling
and storage procedures. Sampled specimens were anonymously
coded and sent to 1 of 5 reference laboratories (RLs) located in dif-
ferent Italian regions (Tuscany, Sardinia, Sicily, Molise, and Lazio).
Colonoscopy devices included in this study were Olympus (Lake
Success, NY) or Pentax (Montvale, NJ) and all underwent precleaning
and manual cleaning procedures according to the endoscope man-
ufacturer’s instructions.24,25 Briefly, the HLD was performed by
automated endoscope reprocessors: CISA (ERS,Milan, Italy), Olympus,
Medivators (Minntech, MN), and Pentax. After HLD, all endoscope
channels were rinsed and forced air was used to dry the channels.
Each RL performed DNA extraction and amplification as well as sam-
pling and processing of their own samples. In each RL, 1 operator
was responsible for all DNA extractions and real-time PCR. The RL
received all supplementary materials for processing the samples,
including DNA extraction kits (QIAmp DNA Mini Kit and DNeasy
Blood & Tissue Kit; Qiagen, Hilden, Germany), NAO (nucleic acids
optimizer) basket (Copan Italia), lysozyme solution and glass beads,
1 spiked sample as an internal positive control, the Microsan-F Kit
(MDD University Spin Off, Viterbo, Italy) containing standardized
amplification mix with aliquots of positive and negative controls,
and the protocol. All kits and reagents were from the same batches.
Sampling
Each PU identified and sampled at least 10 colonoscopy devices:
5 dirty and 5 clean. For sampling, each nylon-tipped flocked swab
was wiped on a surface area of 5 cm2 (initially, inner channel sam-
pling was considered, showing similar results, but in this preliminary
phase of the study the simplest and most reproducible approach
was selected, applied, and reported). Samples were collected using
aseptic techniques in a dedicated room. In addition to routine moni-
toring, randomly selected additional samples (n = 40) were also
collected to be analyzed by classic microbiology, following Centers
for Disease Control and Prevention and European Society of Gas-
trointestinal Endoscopy and European Society of Gastroenterology
and Endoscopy Nurses and Associates (ESGE-ESGENA) protocols.16,26
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Briefly, the swabs were vortexed for 5minutes in 10mL sterile phos-
phate buffered saline and an aliquot of 1 mL was inoculated onto
tryptic soy agar (total microbiology count), violet red bile dex-
trose agar (Enterobacteriaceae), and Baird-Parker agar (staphylococci)
and plates were incubated aerobically at 37°C for 24-48 hours. Pure
cultures were presumptively identified based on their morpholo-
gy, colonial, and Gram staining characteristics. Their identity was
confirmed by the oxidase, catalase, coagulase, motility, growth on
Kliger iron agar, and the analytical profile index 20E assay
(BioMerieux SA, Mercy l’Etoille, France).
Optimization of DNA extraction protocol and interlaboratory
validation test
To simplify the extraction protocol, preliminary tests were per-
formed and 2 different approaches for DNA extraction were
considered, using traditional cotton swabs (GMBH, Germany) and
nylon-tipped flocked swabs with active drying agent (Copan Italia).
The comparison of the protocols and the optimization tests were
performed preparing mock contaminated swabs (about 104 CFU),
using a solution from fecal samples or a pure culture of Enterococ-
cus faecalis ATCC 7080.
Protocol 1 has been described elsewhere,23 but appeared too
labor- and time-consuming for routine surveillance. Briefly, each
swab was washed in 500 μL sterile phosphate buffered saline buffer
(AppliChem GmbH, Darmstadt, Germany) at room temperature in
agitation for 45 minutes. After the removal of the swab, the buffer
was centrifuged at 16,000 × gram and the bacteria pellet was frozen
at –20°C. After adding the glass beads (Sigma-Aldrich, St Louis, MO)
the pellet was manually disaggregated with a pestle and lysed in
200 μL lysozyme solution, RNaseA treated, and proteinase K di-
gested according to the GenElute Bacterial Genomic DNA Kit (Sigma-
Aldrich). Finally, DNA elutionwas performed in 50 μL elution solution
(10 mM tris(hydroxymethyl)aminomethane-hydrochloride and
0.5 mM ethylenediaminetetraacetic acid, pH 9.0).
Protocol 2 was set up to provide a more rapid and transferable
procedure in hospital surveillance settings. Briefly, each swab was
extracted using the QIAamp DNA Mini (QIAmp DNA Mini Kit and
DNeasy Blood & Tissue Kit) according to the DNA purification from
buccal swabs procedure with minor modifications, and using the
NAO Baskets. After sample collection, each swab was inserted into
the semipermeable NAO Baskets andwas broken inside at the break-
point. Approximately 200 μL lysozyme solution (20mg/mL Lisozima
[Sigma-Aldrich], 20 mM tris[hydroxymethyl]aminomethane-
hydrochloride at pH 8, 2 mM ethylenediaminetetraacetic acid, and
1.2% Triton X-100 [Sigma-Aldrich]) were added into the NAO Baskets
and incubated a 37°C for 30 minutes. Then, 20 μL proteinase K and
400 μL buffer AL were added and the sample was centrifuged at
10,000 × g for 1 minute, allowing the elution of the digestion so-
lution. After incubation at 56°C for 10 minutes and addition of 400
μL ethanol, the washing step and DNA purification were per-
formed in accordance with the manufacturer’s instructions. DNA
elution was completed in 60 μL elution solution (10 mM
tris[hydroxymethyl]aminomethane-hydrochloride and 0.5 mM
ethylenediaminetetraacetic acid at pH 9.0).
Preparation of spiked samples for interlaboratory validation
The 5 RLs participated in an internal survey to validate the
adopted approach. Each RL received in blind a spiked swab for DNA
extraction and amplification. The spiked samples consisted of 100
μL fresh bacterial suspension of E faecalis corresponding to 105 CFU,
spotted on nylon swabs and sent from the Coordinating Laborato-
ry Unit to each RL. DNA was extracted according to protocol 2 and
analyzed in parallel in all laboratories.
Analysis of mfDNA by multiplex real-time PCR and data
interpretation
Amplifications were combined in 3 multiplex reactions
(Microsan-F Kit; MDD, Viterbo, Italy): mix F1, for the identifica-
tion of Staphylococcus aureus/Enterococcus spp; mix F2 for Bacteroides
fragilis/Bacteroides vulgatus; mix F3 for B vulgatus/Escherichia coli
(probes were labeled FAM/JOE/ROX, with the BHQ-1 quencher). Re-
actions were performed in a volume of 25 μL, of which 12.5 μL
JumpStart Taq ReadyMix for Quantitative PCR (Sigma Aldrich, St.
Louis, MO), containing 900 nM forward and reverse primers, and
250 nM of each probe. For eachmix, samples were tested in triplicate.
The amplifications were performed using different instru-
ments: ABI PRISM 7000 and 7900 HT (Life Technologies),
Mastercycler (Eppendorf, Milan, Italy), Bio-Rad CFX96 (Bio-Rad, Her-
cules, CA) programmed for 10 minutes at 95°C and 40 cycles of
15 seconds at 95°C and 1 minute at 60°C. For each sample 5-10 μL
template reaction was amplified. The PCR output was expressed as
cycle threshold (CT), a measure of the quantity of detected DNA. Pos-
itive samples were considered those where CT data analysis provided
at least 1 positive indicator (CT ≤ 33) in at least 2 mixes. Converse-
ly, a microbial indicator was considered negative when over the
CT ≥ 33 threshold.
Statistical data analysis
The experimental tests were performed in triplicate and quan-
titative data were summarized usingmeans and standard deviations.
The performance of mfDNA analysis in the interlaboratory exper-
imental study and in the multicenter survey was calculated in terms
of sensitivity, specificity, false positive and false negative rates, ef-
ficiency, and selectivity, as follows: sensitivity: a/(a + b); specificity:
d/(c + d); false positive rate: c/(a + c); false negative rate: b/(b + d);
efficiency: (a + d)/n; and selectivity: Log10 [(a + c)/(a + b + c + d)] where
“a” is the number of true positives, “b” is the number of false posi-
tives, “c” is the number of false negatives, “d” is the number of true
negatives, and “n” is the number of samples. False negatives were
considered all those samples testing negative in used and/or not fully
sanitized devices; false positives were all those samples testing pos-
itive in unused and/or fully sanitized devices.
NGS analysis
NGS samples were prepared according to the 16S Metagenomic
Sequencing Library Preparation guide (part# 15044223 rev A;
Illumina, San Diego, CA). The PCR amplicon was obtained using
primers (containing overhang adapters) as previously described.27,28
Libraries were quantified through PicoGreen dsDNA Quantitation
Assay (ThermoFisher Scientific, Waltham, MA) and validated on
Bioanalyzer DNA 1000 chip (Agilent, Santa Clara, CA) for the pres-
ence of the expected amplicon. Sequencing was performed on a
MiSeq desktop sequencer (Illumina). The sequence reads were ana-
lyzed in the cloud environment BaseSpace through the 16S
Metagenomics app (version 1.0.1; Illumina): the taxonomic data-
base used was an Illumina-curated version of the May 2013 release
of the Greengenes Consortium Database (greengenes.secondgenome
.com); the classification algorithm was an implementation of the
Ribosomal Database Project Classifier.29 The Principal Coordinates
Analysis was generated through the 16S Metagenomics app using
classic multidimensional scaling on a Pearson covariance distance
matrix created from per-sample normalized classification abun-
dance vectors. Detection cutoff was set at 1%. NGS analysis was
performed on a subset of positive samples (n = 48), whenever enough
DNA was available for this additional experiment.
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RESULTS
Optimization of DNA extraction protocol and interlaboratory
validation of the real-time PCR approach
The optimization of the DNA extraction protocol was required
to simplify themonitoring procedure and acquire amore easily trans-
ferable and routinely acceptable protocol. It was successfully
achieved, reducing the labor- and time-consuming steps; results are
reported in Figure 1. Adequate yield of amplifiable DNA was always
obtained (>20 ng/μL) from mock-contaminated swabs, allowing us
to obtain CT values in the range of 18.5-25.6. Protocol 2 using nylon
flocked swabs was the most rapid (1.5 vs 3.5 hours) and effective
(CT of 19 vs 24) method, allowing amplification at a lower CT number,
with an higher sensibility corresponding to more than an addition-
al log for DNA recovery (ΔCT > 5).20 For this reason, we finally adopted
protocol 2 and nylon flocked swabs to perform the interlaboratory
test between the 5 RLs. All laboratories successfully applied the pro-
tocol, performing DNA extraction and real-time amplification of
spiked samples and obtaining consistent results with CT values
ranging from 11.0-15.1 (mean, 13.2 ± 1.7). An additional
interlaboratory test was performed comparing the amplification
outputs obtained by amplifying the DNA standard controls using
different PCR instruments. All laboratories identified and quanti-
fied correctly each target species within the different multiplex
reactions, independently by the equipment, and providing a CT within
an acceptable range (mean, 18-28). The optimized protocol was easily
and successfully applied in all laboratories and both DNA extrac-
tion and amplification steps were validated.
In-field multicenter survey
A total of 111 samples from colonoscopy devices, including used
devices (n = 59) and fully reprocessed endoscopes (n = 52), were col-
lected by the 10 PUs and processed by the 5 RLs. The results from
the in-field multicenter survey are summarized in Table 1. Regard-
ing the used devices, 98% resulted clearly positives and only 1 sample
was not amplifiable by any indicator in any of the multiplex am-
plification mixes (sample 10 s). The majority of samples collected
from fully reprocessed colonoscopy devices resulted in clear nega-
tives (90.4%), whereas in 5 samples mfDNA traces were detected
(at least 2 markers in at least 2 amplification mixes), suggesting a
possible failure in reprocessing (samples 23p, 26p, 28p, 31p, and
43p).
No single microbial indicator could explain all the observed pos-
itive samples, but the combination of the different target genes for
the selected microbial markers produced satisfying results. In par-
ticular, B vulgatus 16S amplicon accounted for 92.2% of positive
results (59 out of 64), B vulgatus OmpA accounted for 70.3% (45 out
of 64), Enterococcus faecalis accounted for 65.6% (42 out of 59), Es-
cherichia coli accounted for 65.6% (42 out of 64), B fragilis accounted
for 51.6% (33 out of 64), and S aureus accounted for 35.6% (23 out
of 64). Whenever B vulgatus 16S amplicon was not detected, B
vulgatus OmpA and/or Enterococcus faecalis were present, account-
ing for about 87% of samples (8 out of 59) from not-reprocessed
endoscopes, and 80% of reprocessed endoscopes (1 out of 5) that
were identified as positive. However, the simultaneous use of all 3
amplification mixes with the selected combination of primers pro-
vided an acceptable rate of positivity (>98%). Furthermore, internal
negative and positive controls were always satisfied in all the assays
performed by the RLs using the different instruments.
NGS analysis
To confirm the presence of the specific gut microbiota on the pos-
itive samples and exclude accidental contaminations or real-time
PCR artifacts, samples identified as positive were tested by NGS,
whenever sufficient DNA was available, for a total of 48 positive
samples analyzed. Particularly, NGS analysis was performed on used/
not-reprocessed devices (45 out of 58 [77.6%]) and fully reprocessed
devices (3 out of 5 [60%]), showing a clear correspondence between
real-time PCR data and gut origin (intestinal microbiota) of the
mfDNA traces collected by swab sampling. The NGS analysis was
valid, providing a sufficient total number of reads passing the quality
filter (n = 5,835,693) and all samples presented at least 100,000 reads
submitted for bioinformatic analysis.30 Classification showed that
Fig 1. Optimization of sampling and DNA extraction. DNA recovery with extraction in protocol 1 and 2 using (A) cotton and (B) nylon swabs and final interlaboratory test
using protocol 2 for DNA extraction. ●, fecal; ■, Enterococcus faecalis; ▴, validation sample.
Table 1
Multicentric survey summary. Testing of colonoscopy devices by the microflora DNA
real-time polymerase chain reaction method
Used Reprocessed Total
Total samples 59 52 111
Positive samples* 58 5 63
Negative samples 1 47 48
*At least 1 positive indicator (cycle threshold < 33) in at least 2 mixes.
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Bacteroides genus was most represented (reads, 13.7%-68.2%; mean,
33.3% ± 15.3%) with the exception of some samples dominated by
Enterococcus genus (6s, 22s, 39s, 41s, and 5s; mean, 83.5% ± 10.1%),
in agreement with real-time PCR data. NGS analysis also con-
firmed that the fully reprocessed devices (31p, 28p, and 43p) were
positive for mfDNA traces, suggesting possible failures in colonos-
copy device reprocessing. In these samples, NGS allowed detection
of the presence of additional fecal bacteria genus, typical of intes-
tinal biologic fluid and gut microbiota, such as Clostridium and
Faecalibacterium.
Evaluation of method performance
Data from interlaboratory tests and in-field surveys were
used to evaluate the performance of the method, as reported in
Table 2. In-field performance of the method was defined after con-
firming doubt samples by classic microbiology and/or NGS data.
Interlaboratory assay using spike swabs provided the highest sen-
sitivity and specificity values (100%), whereas slightly lower values
(98%) were obtained by the in-field survey. Initially, raw in-field data
provided acceptable but lower values for sensibility (92%). However,
not all true-positive samples were confirmed by microbiology and/
or NGS as clean and fully reprocessed samples. These apparently
fully reprocessed colonoscopy devices that resulted in positive results
by real-time PCR were further verified to exclude method failures
or laboratory errors. In particular, sample 23p came back positive
also using classic microbiology monitoring, so it was considered a
true positive. Samples 28p, 31p, and 43p were confirmed positive
by NGS analysis as showing presence of gut microbiota and there-
fore all were considered true positives. For sample 26p, additional
DNA was not available for NGS, but because it was negative at mi-
crobiologic analysis, it was prudently considered a false positive.
Based on this additional information, in-field performance values
were updated as reported in Table 2, with a further increase in ef-
ficiency, from 95% to 98%. However, both performance evaluations—in
lab and in field—support an acceptable performance for the tested
real-time PCR method, with sensitivity, specificity, and efficiency
between 92% and 100%.
DISCUSSION
Recent studies have reported the possible failure of endoscope
reprocessing even when performed in accordance with profession-
al and manufacturer guidelines.5,7-12 Residual presence of organic
materials and biological debris not fully removed during cleaning
represents a risk for cross-infections and can reduce the HLD
effectiveness.3 Endoscopy-transmitted infections have been re-
ported in different settings and appropriate microbiologic
surveillance is strongly recommended by guidelines.9-12 However,
even a negative culture does not completely exclude the possibil-
ity of a contaminated device, as recently underlined by the Centers
for Diseases Control and Prevention.26 Therefore, the availability of
alternative and rapidmethods formonitoring reprocessing is strongly
needed to overcome the limits of culture-based testing and speed
up the endoscope turnover during routine clinical practice. Several
innovative strategies have been introduced that show promising per-
spectives but also unsolved limitations, including the effectiveness
of their performance in surveillance and compatibility with endo-
scope materials.7,18,19 Some of these alternative methods have the
advantage of being very rapid and simple, but they are less sensi-
tive than DNA amplification. Moreover, the different chemical
alternatives are not specific, providing generic information on the
presence of organic contamination and not on its biological nature,
source, or infectious risk.18-21
For the first time, to our knowledge, a DNA-based approach was
applied to examine colonoscopy device reprocessing. A multiplex,
real-time PCR protocol was designed to detect residuals of gut bi-
ological fluid as an indicator of reprocessing failure. The general
principle is the identification of residual organic debris or biolog-
ical fluid traces by the detection of marker genes belonging to the
gut microbiota. Real-time PCR assays were developed targeting 6
genetic markers that resulted simultaneously in 3 independent re-
action mixes. The assays allowed identification of positivity
thresholds (CT < 33) and the acquisition of a microbial signature
typical of that biological fluid, providing rapid and specific infor-
mation on the contamination source and its traceability.28 Indeed,
this strategy was effective in covering the naturally occurring mi-
crobial variability, as confirmed by the NGS data showing a clear
presence of these and other species belonging to the intestinal
microbiota.
Considering the ordinary complexity of surveillance needs in clin-
ical settings, we tried to further simplify both sampling and DNA
purification steps. A procedure based on nylon-tipped flocked swabs
and a dedicated extraction protocol was successfully optimized to
obtain a less labor- and time-consuming method that appeared ef-
ficient and suitable for both gram-negative and gram-positive
bacteria. This protocol was validated in an interlaboratory test,
showing high reproducibility, transferability, and an amplification
at a lower CT number, corresponding to an increased DNA recov-
ery. Finally, with respect to traditional culture-based methods that
require long incubation times (24-72 hours), this protocol allows
faster monitoring of reprocessed devices with a potential influ-
ence on their turnover because the overall specimen analysis required
about 3-4 hours, including both DNA extraction and amplification.
Once the protocol was established, it was applied for the mul-
ticenter survey, involving endoscopy units from 10 different major
Italian hospitals. The sampling protocol was easily applied by all par-
ticipants who followed the provided instructions. Likewise for the
DNA analysis performed in 5 independent laboratories using dif-
ferent real-time PCR instruments. This confirms the high
transferability of the method. Of sampled colonoscopies, 98.2% were
correctly assigned by real-time PCR analysis and further con-
firmed by microbiology or NGS. The PCR assays allowed detection
of 4 reprocessing failures, supporting the effectiveness of the strat-
egy in endoscope surveillance and in monitoring local sanitation
procedures. The overall performance of the method was 100% in the
experimental interlaboratory testing andwhen calculated in the field
during the multicenter survey.
The results of this multicenter survey support a promising ap-
plicability of the proposedmethod in the surveillance of reprocessed
colonoscopy devices. Additional benefits are related to shorter turn-
over of endoscopy devices, whereas surveillance culture results
would still be pending. However, limitations could be related to the
DNA-based analysis. First of all, a molecular biology laboratory
equipped with real-time PCR platforms is required and this may not
be available in small hospitals. In our study, 50% of the involved hos-
pitals would have been able to carry out the analysis autonomously,
Table 2
Method performance. Experimental test performed in laboratory under controlled
conditions and in field test based on the multicentric survey data
Characteristic
Results
Experimental test In-field test
Sensitivity, % 100 98
Specificity, % 100 98
Efficiency, % 100 98
False positives 0 0.017
False negatives 0 0.02
Selectivity −0.06 −0.30
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directly or by making arrangements with a laboratory within the
hospital. The extreme sensitivity of the PCR amplification tech-
nique can cause laboratory artifacts due to minimal carryover
contaminations. This concern can be avoided by good laboratory
practice, using dedicated consumables, performing the analysis
within a hood, and including additional negative controls. It is also
important to underline that identification of microbial markers by
DNA amplification does not imply an infective capability due to the
presence of alive pathogens, but can reveal the presence of con-
taminants from a previous patient, indicating a possible reprocessing
failure. A further limitation is related to hypothetical drastic dis-
ruptions of the natural microbiota composition; for example, due
to pathogens and/or antibiotic therapies that would have eradi-
cated any of the bacteria species selected for the PCR analysis. This
condition was not observed in any of the used endoscopes tested
in our survey (confirmed by Metagenomics); nevertheless, it could
be overcome by further increasing the number of detectable species.
Lastly, NGS itself, even if it providedmore informative output, would
not be appropriate for routine monitoring, not only because it is
highly expensive and rarely available in hospitals, but also because
of the long time required for the analysis and bioinformatic inter-
pretation of output. NGS can, however, represent an approach for
confirming doubt results and studying particular cases of scientif-
ic or legal medical interest. Therefore, the proposed real-time PCR
strategy appears to be the most suitable method for rapid and spe-
cific monitoring by DNA analysis. In the long-term, its application
may also support the identification of critical points in local repro-
cessing procedures or their validation and implementation.
Conclusions
In conclusion, the results of our survey strongly support the ap-
plication of real-time PCR-based assays in surveillance of
reprocessing, especially in combination with the reported simpli-
fied protocol for mfDNA isolation using nylon-tipped flocked
swabs+NAO® baskets. This promising approach deserves atten-
tion and further studies to confirm its reliability as a feasible support
to flank traditional microbiology monitoring and update guidelines.
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